Considering all these results, it is thought that thedeveloped immunosensor has application potential for rapid minimal-invasivedetection of CD36, which is a biomarker for atherosclerosis, prediabetes,and DM in clinical analysis. This evidence concerns the gene CD36 and prediabetes syndrome.